Stock screenerAll disclosures →
EDGAR →
NVST
Conviction 72HealthcareScan · Tue, Sep 8, 2026NVST$26.82-1.70%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price26.82
Change-1.70%
Gap-1.01%
Rel volume1.29×
Avg volume2.2M
Avg $ vol60.6M
SMA 2027.53
SMA 5027.22
SMA 20025.34
Price vs 50-1.47%
Price vs 200+5.84%
MA stackmixed
50/200 cross—
Supertrendup · 25.72
RSI (14)45
MACD hist-0.09
MACD cross—
Stoch %K / %D10 / 28
ADX (14)16
+DI / −DI23 / 19
RSI divergence—
MACD divergenceBullish
ATR %+3.07%
ADR %2.94%
52w high30.26
52w low18.95
From 52w high-11.38%
Above 52w low+41.50%
New 52w highNo
SqueezeOn · 3d
Bollinger width7.52%
%B0.15
Donchian pos9.15%
Donchian high29.00
Donchian low26.60
AVWAP (52w high)26.26
vs AVWAP high+2.10%
AVWAP (52w low)24.99
vs AVWAP low+7.32%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d1.29×
Avg vol (14d)2M
Avg vol (20d)2.2M
Avg $ vol (20d)60.6M
Market cap4.31B
RS 3m (vs SPY)+13.67%
RS 6m (vs SPY)-12.98%
RS line new highNo
Trend template7/8
Technical rank42.8
1 week-1.20%
1 month-4.74%
3 months+14.40%
6 months+0.43%
1 year+25.83%
YTD+23.63%
P/E91.64
P/B1.40
P/S1.58
P/FCF18.69
EPS0.2800
Div yield—
ROE1.53%
ROA0.84%
Debt/Eq0.47
Current2.43
EV/EBITDA13.90
Gross margin54.67%
Net margin1.73%
Rev growth8.32%
EPS growth104.20%
Price target30.55
Target upside13.93%
Analyst ratingBuy
Institutional129.30%
Ent. value4.62B
Revenue730.5M
Net income53.7M
Gross profit407M
Free cash flow230.4M
IndustryDENTAL EQUIPMENT & SUPPLIES
ExchangeNYSE
Shares out162.73M
Employees12K
ListedWed, Sep 18, 2019
Free float160.91M
Float %98.2%
Short interest9.63M
Days to cover2.6d
Short volume80.7%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.41 vs $0.33
Last surprise+24.2% beat
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank42.8 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance28.91
Support26.18
Days since event—
Candle confirm—
News sentiment—
Financials as of Fri, Jul 3, 2026 · quarterly.
Recent news
- Envista Announces Participation in Baird 2026 Global Healthcare ConferencePR Newswire · Tue, Sep 8, 2026
Congress activity
Disclosed STOCK Act trades in NVST · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Pete Sessions house · TX · traded 2024-06-06 | Sell | $1K–$15K | 2024-06-06 | 2024-06-06 |
Insider activity
SEC Form 4 transactions in NVST · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Acurio Veronica President, Orthodontics · Common Stock · 2026-08-25 | Tax | 7.71K | $212K | 2026-08-25 | 2026-08-27 |
Befidi Robert President, Diagnostics · Common Stock · 2026-08-25 | Tax | 5.15K | $141K | 2026-08-25 | 2026-08-27 |
Hammes Eric D. Chief Financial Officer · Common Stock · 2026-08-25 | Tax | 10.88K | $299K | 2026-08-25 | 2026-08-27 |
Nilsson Stefan President, Nobel Biocare · Common Stock · 2026-08-25 | Tax | 804 | $22K | 2026-08-25 | 2026-08-27 |
Reis Mischa SVP, Strategy & Bus. Dev. · Common Stock · 2026-08-20 | Sell | 8K | $220K | 2026-08-20 | 2026-08-24 |
Keel Paul A Chief Executive Officer · Performance Share Unit · 2026-08-18 | Grant | 159.9K | — | 2026-08-18 | 2026-08-20 |
Hammes Eric D. Chief Financial Officer · Performance Share Unit · 2026-08-18 | Grant | 47.97K | — | 2026-08-18 | 2026-08-20 |
Keel Paul A Chief Executive Officer · Common Stock · 2026-08-18 | Grant | 179.73K | — | 2026-08-18 | 2026-08-20 |
Keel Paul A Chief Executive Officer · Common Stock · 2026-05-25 | Tax | 12.81K | $300K | 2026-05-25 | 2026-05-27 |
Raskas Daniel Director · Common Stock · 2026-05-19 | Grant | 9.33K | $0 | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in NVST · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.